Replimune Group, Inc.
No financial data available for REPL.
Company may not file with SEC or CIK is unresolved.
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | 2026-06-03 | Sarchi Christopher | Chief Commercial Officer | Sale | 12.0K | $9.24 | $111K | 181.0K | View | |
| 2026-05-18 | 2026-05-20 | Xynos Konstantinos | Chief Medical Officer | Sale | 14.0K | $5.08 | $71K | 235.7K | View | |
| 2026-05-18 | 2026-05-20 | Schwendenman Andrew | Chief Accounting Officer | Sale | 7,894 | $5.08 | $40K | 107.1K | View | |
| 2026-05-18 | 2026-05-20 | Sarchi Christopher | Chief Commercial Officer | Sale | 8,626 | $5.08 | $44K | 193.0K | View | |
| 2026-05-18 | 2026-05-20 | Astley-Sparke Philip | Director | Sale | 17.7K | $5.08 | $90K | 1.41M | View |
Informational purposes only, not investment advice.